- $1.76bn
- $1.54bn
- $7.40m
Brief: Ambrx Announces Closing Of $75 Million Market Priced Registered Offering
U.S. RESEARCH ROUNDUP-Catalent, Estee Lauder Companies, Marqeta
U.S. RESEARCH ROUNDUP-Apple, Cabot, Epam Systems
Brief: Ambrx Announces $75 Mln Market Priced Registered Offering
Brief: Ambrx Appoints Stephen Glover As Chairman Of Its Board Of Directors
Brief: Ambrx Biopharma Inc Files For Stock Shelf Of Up To $300 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Tesla, Neptune Wellness, Ardelyx